You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 117 No. 11, November 1981 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Antibodies to Melanocytes

Occurrence in Patients With Vitiligo and Chronic Mucocutaneous Candidiasis

Nancy Howanitz, MD; James L. Nordlund, MD; Aaron B. Lerner, MD; Jean-Claude Bystryn, MD

Arch Dermatol. 1981;117(11):705-708.


Abstract



• The prevalence of antibodies to melanocytes was determined by an immunofluorescence complement fixation technique in 294 patients with vitiligo, other pigmentary disorders, and unrelated dermatoses. Antimelanocyte antibodies were present in the sera of five (29%) of 17 patients with chronic mucocutaneous candidiasis. Only two of the five patients with antibodies had vitiligo. No antibodies to melanocytes were found in the sera of 31 patients with common vitiligo or of 38 patients with vitiligo associated with autoimmune diseases or melanoma. Nor were antibodies to melanocytes found in 129 patients with other diseases of pigment-producing cells or in a control group of 79 patients with nonpigmentary dermatoses. These results suggest that complement fixing antibodies to melanocytes are associated with chronic mucocutaneous candidiasis but are not involved in the pathogenesis of common vitiligo.

(Arch Dermatol 1981;117:705-708)



Author Affiliations



From the Immunofluorescence Laboratory, Department of Dermatology (Drs Howanitz and Bystryn), New York University School of Medicine, New York; and the Departments of Dermatology, Yale University School of Medicine (Dr Lerner) and the West Haven Veterans Administration Medical Center (Dr Nordlund), New Haven, Conn.


Footnotes



Accepted for publication Jan 9, 1981.

Reprint requests to Department of Dermatology, New York University School of Medicine, 560 First Ave, New York, NY 10016 (Dr Bystryn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vitiligo Antibodies Are Not Directed to Tyrosinase
Xie et al.
Arch Dermatol 1999;135:417-422.
ABSTRACT | FULL TEXT  

Nutrition and Its Relationship to Autism
Adams and Conn
Focus Autism Other Dev Disabl 1997;12:53-58.
ABSTRACT  

Complement-Fixing Activity to Melanin-Producing Cells Preceding the Onset of Vitiligo in a Patient With Type 1 Polyglandular Failure
Betterle et al.
Arch Dermatol 1992;128:123-124.
ABSTRACT  

Autoantibodies and Their Clinical Significance in a Black Vitiligo Population
Grimes et al.
Arch Dermatol 1983;119:300-303.
ABSTRACT  

Chronic Mucocutaneous Candidosis: An Update
Jorizzo
Arch Dermatol 1982;118:963-965.
ABSTRACT  

Vitiligo: It Is Important
Nordlund and Lerner
Arch Dermatol 1982;118:5-8.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.